Zoonotic & Vector-Borne Diseases

About 1.6 million individuals die from violence each year on a global scale—do infectious disease physicians have a role in preventing it?

Public health officials cite zoonotic disease as the top pandemic threat, yet the task of predicting or preparing for a pandemic remains difficult.

The first documentation of the east Asian tick Haemaphysalis longicornis in the United States has been described in a recent study.

As an outbreak of Lassa fever in Nigeria continues to spread, the Coalition for Epidemic Preparedness Innovations is working with Themis Bioscience to develop a vaccine to protect against the virus.

The program can detect viral hemorrhagic fevers about 12 days faster than previous efforts.

In the wake of news of 10 travelers being infected with yellow fever, 4 of whom have died, the Centers for Disease Control and Prevention (CDC) are urging anyone considering travel to yellow fever endemic regions of Brazil to be vaccinated prior to travel.

In case you missed them, we've compiled the top five infectious disease articles from this past week.

For use as donor screening tests on samples from individual human donors, the tests will identify antibodies to Babesia microti in human plasma samples and B. microti DNA in human whole blood samples.

An outbreak of Lassa fever in Nigeria that began at the start of the year has now soared to become the country’s biggest outbreak of the virus to date. Nigerian and global health officials are now working together to stop the outbreak.

The new test can differentiate between Lyme disease and 7 other tick-borne diseases.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

These pathogens can cause unique challenges for clinicians.

Contagion® Peer Exchange panelists attempt to reach a consensus on the existence of chronic Lyme disease.

Massive vaccination campaigns launched in Brazil and Nigeria strive to quell ongoing outbreaks.

A recent report documents the first recorded case of a human infestation with the cattle eyeworm Thelazia gulosa.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

A panel of experts from the Philippines Department of Health finds that Sanofi Pasteur's dengue fever vaccine, Dengvaxia (CYD-TDV), may be connected with 3 deaths.

Leonard Sigal, MD, explains his approach for treating Lyme disease patients with persistent symptoms.

Infectious disease specialists and public health professionals in search of a to-do list for 2018 need look no further.

Recognition of chronic Lyme disease and the role of long-term antibiotic treatment for persistent symptoms continue to be controversial among researchers, providers, patients, and advocates.

A new systematic review of published research suggests that methotrexate could potentially be the best co-treatment option for chronic arthritis associated with the chikungunya virus.

Following an outbreak of norovirus in Pyeongchang ahead of the Winter Olympics, health officials are taking steps to stem the outbreak and keep attendees healthy.

A small portion of individuals with Lyme disease continue to have symptoms of arthritis long after treatment. Now, scientists think they have a better understanding of the cause of that lingering reaction.

Grifols receives approval from the FDA for a new higher potency formulation of HyperRAB rabies immune globulin for rabies post-exposure prophylaxis.

Contagion® celebrates its second year this month amid celebrations of bringing in its highest readership traffic to-date.

Researchers from the Wellcome Sanger Institute and collaborators find that a multidrug-resistant strain of malaria spread throughout Cambodia 5 years before clinical resistance was even reported.

E. Canadensis tapeworms may be under-recognized in the United States.

Emerging and neglected tropical diseases are on the rise in Texas, and now, a new paper explores what state health officials need to do in response.

The FDA grants Fast Track designation to TAK-426, Takeda’s purified, inactivated, alum-adjuvanted whole Zika virus vaccine candidate.

Leonard Sigal, MD, explains his approach for treating patients who may have “Lyme anxiety.”